Roflumilast
NDC 72205-200, Roflumilast, tablet, from Novadoz Pharmaceuticals LLC.
- Product NDC
- 72205-200
- Status
- Listed
- Labeler
- Novadoz Pharmaceuticals LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208256
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72205-200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ROFLUMILAST500 ug/1
Pharmacologic classes
Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72205-200-06 | 72205020006 | 10 BLISTER PACK in 1 CARTON (72205-200-06) / 10 TABLET in 1 BLISTER PACK (72205-200-11) |
| 72205-200-30 | 72205020030 | 30 TABLET in 1 BOTTLE (72205-200-30) |
| 72205-200-90 | 72205020090 | 90 TABLET in 1 BOTTLE (72205-200-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4d25f69c-58b7-4e2a-b835-4d0c76a83c7cNADAC price for package 72205020030
GET /v1/drugs/nadac/72205020030NADAC price for package 72205020090
GET /v1/drugs/nadac/72205020090
Use it
Look up 72205-200 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72205-200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72205-200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.